Clinical trials for Cancer in United States

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

Study ID: NCT05600686

Sponsor

Joseph Tuscano

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

Study ID: NCT06047886

Sponsor

University of Alabama at Birmingham

VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer

Study ID: NCT03690986

Sponsor

Emory University

Myriad™ Augmented Soft Tissue Reconstruction Registry

Study ID: NCT05243966

Sponsor

Aroa Biosurgery Limited

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Study ID: NCT04872166

Sponsor

Edgewood Oncology Inc.

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

Study ID: NCT04467801

Sponsor

Jun Zhang, MD, PhD

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Study ID: NCT06398457

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

UPLYFT For Lymphoma Survivors

Study ID: NCT05080166

Sponsor

Dana-Farber Cancer Institute

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Study ID: NCT04099966

Sponsor

Mitchell Cairo

Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Study ID: NCT05814666

Sponsor

Flamingo Therapeutics NV